TrialArthritis research & therapy2021

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.

Proton Rahman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.